The DOI matches its Crossref record.
Chronic fatigue syndrome
Abstract
GENERAL PURPOSE: To gain knowledge about CFS, including the pathophysiology, clinical manifestations, diagnostic criteria, and management strategies. LEARNING OBJECTIVES/OUTCOMES: After completing this continuing-education activity, you should be able to: 1. Summarize the epidemiology, pathophysiology, and clinical manifestations of CFS. 2. Identify the appropriate diagnostic and treatment approaches for patients with CFS. CFS is also referred to as fibromyalgia. Epstein-Barr viral infection. systemic exertion intolerance disease. CFS is more likely to be diagnosed in patients who are male. middle age. adolescent. Immune system changes that occur with CFS involve a reduced number of cytokines. abnormal functioning of white blood cells. an increased ability to use energy on the cellular level. The pathophysiology of CFS includes a dysregulation of several limbic-hypothalamic-pituitary-adrenal axes that affect levels of certain hormones such as cortisol. glucagon. thyroid-stimulating hormone. Another factor that may contribute to the pathophysiology of CFS is neuroinflammation. decreased lactate levels. spots in the brain's gray matter. While assessing the patient's medical history, he reveals experiencing fatigue that doesn't improve with rest and can't be explained by an underlying medical disorder. This description is the hallmark of CFS. a rare symptom of CFS. not associated with CFS. The newly diagnosed patient with CFS asks about long-term disabilities. The patient is advised that about half of individuals affected by CFS experience “crash” reactions daily. are able to return to work, either full or part time. are house- or bedbound at some point during their illness. The patient calls the healthcare provider's office and states that she's currently experiencing a “crash,” which is also identified as a phenomenon called Sjögren syndrome. daytime hypersomnia. PEM. The newly diagnosed patient asks about common manifestations of CFS. It's explained that many individuals with CFS experience nighttime insomnia. normal rhythm and quantity of sleep. an increase in BP upon standing. When assessing a patient for CFS, it's helpful to ask about common comorbidities that are present with this disorder, such as asthma. psoriatic arthritis. postural tachycardia syndrome. The National Academy of Medicine proposed which of the following as a diagnostic criterion for CFS when accompanied by cognitive impairment and/or orthostatic intolerance? a substantial reduction in activity that lasts for at least 3 months persistent headaches that occur at the onset of PEM profound, new-onset fatigue unrelated to exertion and not relieved with rest A nanoelectronic assay test is an accepted biomarker test used to diagnose CFS. an investigational blood test with 100% accuracy in one study. a test to identify a specific antigen that causes CFS. Some studies have shown positive short-term results for patients treated with modafinil. hydrocortisone. methylphenidate. Which drug resulted in some improvement for patients with CFS but without enough epidemiologic significance to become the gold standard of treatment? selegiline donepezil nefazodone The primary goal of CFS treatment is helping patients improve their quality of life through symptom relief. GET. CBT. Nonpharmacologic therapies that may be recommended for patients with CFS include aromatherapy. phototherapy. acupuncture. It's important for healthcare providers to encourage patients with CFS to be as active as their energy allows. limit activity to the barest minimum. avoid taking a rest after a period of activity. When caring for patients with CFS, interventions to consider include encouraging ambulation without standby assist for patients with orthostatic intolerance. providing supplements as desired even if there's a known interaction with the treatment regimen. inquiring about vitamins to avoid interactions with prescribed medications. It's important to note that many patients with CFS have elevated BP. have no functional impairment. show no outward signs of illness. According to Dr. Unger, the predominant concern of patients with CFS and their families is accepting that there may never be any improvement in symptoms. the challenges of leading a productive life with CFS symptoms. the difficulty of finding informed and compassionate healthcare providers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Carruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., Bested, A. C., Flor-Henry, P., Joshi, P., Powles, A. C. P., et al. (2003) · Journal of Chronic Fatigue Syndrome · doi:10.1300/j092v11n01_02 · Cited by 1,180
Townsend, L., Dyer, A. H., Jones, K., Dunne, J., Mooney, A., Gaffney, F., O'Connor, L., Leavy, D., O'Brien, K., Dowds, J., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0240784 · Cited by 911
White, P., Goldsmith, K., Johnson, A., Potts, L., Walwyn, R., DeCesare, J., Baber, H., Burgess, M., Clark, L., Cox, D., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60096-2 · Cited by 897
Chaudhuri, A., & Behan, P. O. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00411-1 · Cited by 651
Cytokine signature associated with disease severity in chronic fatigue syndrome patients
Montoya, J. G., Holmes, T. H., Anderson, J. N., Maecker, H. T., Rosenberg-Hasson, Y., Valencia, I. J., Chu, L., Younger, J. W., Tato, C. M., & Davis, M. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710519114 · Cited by 402
The Relationship Between Neurally Mediated Hypotension and the Chronic Fatigue Syndrome
Bou-Holaigah, I. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530120053041 · Cited by 384
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
Cortes Rivera, M., Mastronardi, C., Silva-Aldana, C., Arcos-Burgos, M., & Lidbury, B. (2019) · Diagnostics · doi:10.3390/diagnostics9030091 · Cited by 313
Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
the European Network on ME/CFS (EUROMENE), Rasa, S., Nora-Krukle, Z., Henning, N., Eliassen, E., Shikova, E., Harrer, T., Scheibenbogen, C., Murovska, M., & Prusty, B. K. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1644-y · Cited by 312
Old wine in new bottles: neurasthenia and ‘ME’
Wessely, S. (1990) · Psychological Medicine · doi:10.1017/s0033291700013210 · Cited by 265
Fatigue in advanced kidney disease
Artom, M., Moss-Morris, R., Caskey, F., & Chilcot, J. (2014) · Kidney International · doi:10.1038/ki.2014.86 · Cited by 220
A formal analysis of cytokine networks in chronic fatigue syndrome
Broderick, G., Fuite, J., Kreitz, A., Vernon, S. D., Klimas, N., & Fletcher, M. A. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.04.012 · Cited by 202
Rowe, P. C., Calkins, H., DeBusk, K., McKenzie, R., Anand, R., Sharma, G., Cuccherini, B. A., Soto, N., Hohman, P., Snader, S., et al. (2001) · JAMA · doi:10.1001/jama.285.1.52 · Cited by 142
Managing Chronic Pain in Children and Adolescents: A Clinical Review
Landry, B. W., Fischer, P. R., Driscoll, S. W., Koch, K. M., Harbeck‐Weber, C., Mack, K. J., Wilder, R. T., Bauer, B. A., & Brandenburg, J. E. (2015) · PM&R · doi:10.1016/j.pmrj.2015.09.006 · Cited by 128
Gur, A., Cevik, R., Nas, K., Colpan, L., & Sarac, S. (2004) · Arthritis Res Ther · doi:10.1186/ar1163 · Cited by 88
Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome
Loebel, M., Strohschein, K., Giannini, C., Koelsch, U., Bauer, S., Doebis, C., Thomas, S., Unterwalder, N., von Baehr, V., Reinke, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085387 · Cited by 86
The differential diagnosis of tiredness: a systematic review
Stadje, R., Dornieden, K., Baum, E., Becker, A., Biroga, T., Bösner, S., Haasenritter, J., Keunecke, C., Viniol, A., & Donner-Banzhoff, N. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0545-5 · Cited by 83
Strayer, D. R., Carter, W. A., Stouch, B. C., Stevens, S. R., Bateman, L., Cimoch, P. J., Lapp, C. W., Peterson, D. L., the Chronic Fatigue Syndrome AMP-516 Study Group, & Mitchell, W. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031334 · Cited by 84
Voermans, N. C., & Knoop, H. (2011) · Disability and Rehabilitation · doi:10.3109/09638288.2010.531373 · Cited by 81
Lopez, C., Antoni, M., Penedo, F., Weiss, D., Cruess, S., Segotas, M.-C., Helder, L., Siegel, S., Klimas, N., & Fletcher, M. A. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.11.010 · Cited by 71
Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue
Broderick, G., Katz, B. Z., Fernandes, H., Fletcher, M. A., Klimas, N., Smith, F. A., O’Gorman, M. R., Vernon, S. D., & Taylor, R. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-191 · Cited by 72
Small heart syndrome in patients with chronic fatigue syndrome
Miwa, K., & Fujita, M. (2008) · Clinical Cardiology · doi:10.1002/clc.20227 · Cited by 61
Mitchell, W. M. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1172960 · Cited by 57
Cevik, R., Gur, A., Acar, S., Nas, K., & Sarac, A. J. (2004) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-5-47 · Cited by 39
Haines, C., Loades, M., & Davis, C. (2019) · Clinical Child Psychology and Psychiatry · doi:10.1177/1359104519829796 · Cited by 39
Early menopause and other gynecologic risk indicators for chronic fatigue syndrome in women
Boneva, R. S., Lin, J.-M. S., & Unger, E. R. (2015) · Menopause · doi:10.1097/gme.0000000000000411 · Cited by 37
Mensah, F., Bansal, A., Berkovitz, S., Sharma, A., Reddy, V, Leandro, M. J., & Cambridge, G. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12749 · Cited by 34
Metadata
- Venue
- Nursing Management
- Published
- 2020-10
- Volume
- 51
- Issue
- 10
- Pages
- 1-1
- ISSN
- 0744-6314 (ISSN-L)
- OpenAlex
- W3149347414
- Cited by
- 276
- References
- 0
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.